The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the NIH and the FDA Center for Tobacco Products to foster tobacco regulatory research.
With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Within the framework of the Tobacco Control Act, the NIH and FDA formed this partnership to establish a comprehensive research agenda in tobacco regulatory science.
- RFA-OD-22-002: Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed) — Pre-application webinar January 13, 2022 (NOT-OD-22-052)
These FAQs clarify research that is and is not within scope of the FDA’s Center for Tobacco Products (CTP) regulatory authority. Only research that is within the regulatory authority of the FDA CTP will be considered for funding.
The FDA has taken action on over 90% of more than 6.5 million ‘deemed’ new tobacco product applications that were submitted by September 9, 2020, including issuing Marketing Denial Orders for more than 946,000 flavored ENDS products because their applications lacked sufficient evidence that they have a benefit to adult smokers sufficient to overcome the harms posed to youth.
An NIH-FDA partnership to foster tobacco regulatory research.
Research projects on tobacco regulatory research funded through TRSP.
Active funding announcements and application information.
Research topic and project priorities for TRSP funding announcements.
Research tools, publications, statistics, and announcements.